Literature DB >> 1845368

Intermittent claudication--be conservative.

J D Coffman.   

Abstract

Mesh:

Year:  1991        PMID: 1845368     DOI: 10.1056/NEJM199108223250810

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

2.  Controlled trial of high- versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease.

Authors:  C Ranke; A Creutzig; G Luska; H H Wagner; M Galanski; S Bode-Böger; J Frölich; H J Avenarius; H Hecker; K ALexander
Journal:  Clin Investig       Date:  1994-09

3.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.

Authors:  Timothy P Murphy; Alan T Hirsch; John J Ricotta; Donald E Cutlip; Emile Mohler; Judith G Regensteiner; Anthony J Comerota; David J Cohen
Journal:  J Vasc Surg       Date:  2008-04-25       Impact factor: 4.268

5.  The effect of nilvadipine on bloodflow in the dorsal pedis artery in type 2 diabetic patients--a study using duplex Doppler ultrasonography.

Authors:  H Sone; Y Okuda; M Mizutani; Y Kawakami; C Bannai; K Yamashita
Journal:  Postgrad Med J       Date:  1995-10       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.